Fertility to Full Lifecycle: The New Commercial Model for Women’s Health

Women’s health is undergoing a commercial transformation - evolving from a fragmented set of point solutions into a lifecycle-driven market spanning fertility, maternity, menopause, and chronic conditions. What began as employer-sponsored fertility benefits is rapidly expanding into broader workforce health strategies, driven by talent retention, productivity, and rising demand for personalized, longitudinal care.

For employers, payers, and life sciences organizations, this shift presents both opportunity and complexity. While demand is growing, questions remain around designing scalable models that balance cost, access, and outcomes. There is still uncertainty about how to move beyond isolated services toward integrated platforms that deliver measurable value across the full lifecycle. At the same time, innovators are navigating the challenge of building global solutions that reflect local care pathways, reimbursement structures, and cultural expectations.

This roundtable brings together leaders across digital health, payers, and employer ecosystems to explore how women’s health is being redefined as a strategic category rather than just a benefit. The discussion will focus on what it takes to build and commercialize solutions that scale beyond fertility, align with buyer priorities, and deliver sustainable impact across diverse populations.

Join us to discuss:

• How are commercial models in women’s health evolving from fertility-focused benefits to lifecycle-driven platforms?
• What do employers and payers actually value - and how are they measuring ROI across different stages of care?
• What does it take to scale women’s health globally while maintaining quality, access, and equity?